Skip to main content
. 2011 Jun 23;17(2):113–119. doi: 10.3350/kjhep.2011.17.2.113

Table 4.

Reasons for divergence from BCLC recommendations

graphic file with name kjhep-17-113-i004.jpg

CTP, Child-Turcotte-Pugh; FLR, future liver remnant volume; HCC, hepatocellular carcinoma; HTN, hypertension; PEIT, percutaneous ethanol injection therapy; RFA, radiofrequency ablation; TACE, transcatheter arterial chemoembolization; Tx, treatment.